Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoma | 7 | 2024 | 1800 | 1.180 |
Why?
|
Radiation Tolerance | 2 | 2019 | 478 | 1.100 |
Why?
|
Hypopituitarism | 1 | 2023 | 250 | 0.740 |
Why?
|
Therapies, Investigational | 1 | 2018 | 111 | 0.570 |
Why?
|
Biological Assay | 1 | 2019 | 623 | 0.520 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 1322 | 0.470 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 3 | 2013 | 826 | 0.420 |
Why?
|
Radiotherapy | 2 | 2019 | 1500 | 0.420 |
Why?
|
Propionates | 1 | 2013 | 181 | 0.410 |
Why?
|
Neuroprotective Agents | 3 | 2013 | 956 | 0.390 |
Why?
|
Tumor Microenvironment | 2 | 2020 | 3875 | 0.360 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2452 | 0.330 |
Why?
|
Neoplasms | 4 | 2024 | 22142 | 0.330 |
Why?
|
Soft Tissue Neoplasms | 1 | 2018 | 1158 | 0.320 |
Why?
|
Nitriles | 1 | 2013 | 971 | 0.300 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2019 | 0.280 |
Why?
|
Neutrophils | 1 | 2019 | 3763 | 0.270 |
Why?
|
Immunotherapy | 5 | 2024 | 4642 | 0.260 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 2208 | 0.240 |
Why?
|
Toll-Like Receptor 9 | 1 | 2024 | 193 | 0.210 |
Why?
|
Herpesviridae | 1 | 2023 | 104 | 0.210 |
Why?
|
Sarcoma, Experimental | 2 | 2024 | 116 | 0.210 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2024 | 704 | 0.210 |
Why?
|
Toll-Like Receptor 3 | 1 | 2022 | 97 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5665 | 0.190 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8519 | 0.180 |
Why?
|
DNA Polymerase II | 1 | 2020 | 104 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4574 | 0.160 |
Why?
|
Rationalization | 1 | 2018 | 6 | 0.160 |
Why?
|
Whole-Body Irradiation | 1 | 2019 | 432 | 0.160 |
Why?
|
Mice, Inbred Strains | 1 | 2020 | 1762 | 0.150 |
Why?
|
Estrogen Receptor alpha | 2 | 2013 | 582 | 0.150 |
Why?
|
Tumor Escape | 1 | 2020 | 371 | 0.150 |
Why?
|
Fatigue | 1 | 2023 | 1550 | 0.130 |
Why?
|
Cell Tracking | 1 | 2017 | 139 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2019 | 1597 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2019 | 549 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1225 | 0.110 |
Why?
|
Mice | 10 | 2024 | 81330 | 0.110 |
Why?
|
Demyelinating Diseases | 2 | 2013 | 352 | 0.110 |
Why?
|
Oncogenes | 1 | 2019 | 1220 | 0.110 |
Why?
|
Gold | 1 | 2017 | 482 | 0.110 |
Why?
|
Freund's Adjuvant | 1 | 2013 | 144 | 0.110 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2692 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2017 | 1080 | 0.100 |
Why?
|
Estrogen Receptor beta | 1 | 2013 | 169 | 0.100 |
Why?
|
Animals | 11 | 2024 | 168089 | 0.100 |
Why?
|
Nanostructures | 1 | 2017 | 551 | 0.100 |
Why?
|
Carotid Stenosis | 1 | 2018 | 859 | 0.090 |
Why?
|
Adipocytes | 1 | 2017 | 1190 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6819 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6486 | 0.080 |
Why?
|
Axons | 2 | 2013 | 1671 | 0.080 |
Why?
|
Astrocytes | 2 | 2013 | 1341 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18222 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9520 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2813 | 0.070 |
Why?
|
Estrogens | 1 | 2013 | 1522 | 0.070 |
Why?
|
Medical Oncology | 1 | 2018 | 2320 | 0.070 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2018 | 880 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5301 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3313 | 0.060 |
Why?
|
Humans | 11 | 2024 | 761222 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8531 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2023 | 64681 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3517 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2894 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9567 | 0.050 |
Why?
|
Injections, Intralesional | 1 | 2024 | 280 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2270 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10423 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13367 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2023 | 242 | 0.050 |
Why?
|
Melanoma | 1 | 2019 | 5694 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2013 | 5103 | 0.040 |
Why?
|
Methylcholanthrene | 1 | 2019 | 30 | 0.040 |
Why?
|
Middle Aged | 4 | 2023 | 220858 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 22128 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58952 | 0.040 |
Why?
|
Carcinogens | 1 | 2019 | 452 | 0.030 |
Why?
|
Neurons | 2 | 2013 | 9429 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2018 | 311 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2019 | 80675 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30004 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2504 | 0.030 |
Why?
|
Signal Transduction | 2 | 2023 | 23419 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15841 | 0.030 |
Why?
|
Genomic Instability | 1 | 2019 | 709 | 0.030 |
Why?
|
Female | 6 | 2024 | 392552 | 0.030 |
Why?
|
Ablation Techniques | 1 | 2017 | 247 | 0.030 |
Why?
|
Chemokine CCL7 | 1 | 2013 | 30 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 59222 | 0.030 |
Why?
|
Radiometry | 1 | 2018 | 812 | 0.030 |
Why?
|
Gliosis | 1 | 2013 | 245 | 0.030 |
Why?
|
Aquaporin 4 | 1 | 2013 | 161 | 0.030 |
Why?
|
Aged | 3 | 2019 | 169292 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1746 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3044 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 88300 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4107 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 602 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6125 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1831 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2915 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18927 | 0.020 |
Why?
|
Adult | 2 | 2019 | 221120 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1967 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2013 | 14392 | 0.020 |
Why?
|
Spinal Cord | 1 | 2013 | 1807 | 0.020 |
Why?
|
Ligands | 1 | 2011 | 3264 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2011 | 1085 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9478 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11067 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11512 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29688 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41496 | 0.010 |
Why?
|
Male | 3 | 2019 | 360703 | 0.010 |
Why?
|
Inflammation | 1 | 2011 | 10759 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74241 | 0.010 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_